|
|
||||||||
MEMBRANE TRANSPORTERS, ION CHANNELS, AND PUMPS
1Clinical Division of General Internal Medicine, Clinical Department of Internal Medicine and 2Division of Physiology, Department of Physiology and Medical Physics, Innsbruck Medical University, Innsbruck, Austria
Submitted 4 August 2006 ; accepted in final form 2 April 2007
| ABSTRACT |
|---|
|
|
|---|
, and
-melanocyte-stimulating hormone (
-MSH) by measuring PMN migration and cytokine release. To distinguish between individual roles of microvascular endothelial and epithelial cells in transmigration processes, migration of PMN was investigated separately in HK-2 and HDMEC monolayers. Sequential migration of PMN through endothelium and epithelium could be observed and was significantly increased after proinflammatory stimulation with either TNF-
or LPS (3.5 ± 0.58 and 2.76 ± 0.64-fold vs. control, respectively). Coincubation with
-MSH inhibited the transmigration of PMN through the bilayer after proinflammatory stimulation with LPS but not after TNF-
. The bilayers produced significant amounts of IL-8 and IL-6 mostly released from the epithelial cells. Furthermore,
-MSH decreased LPS-induced IL-6 secretion by 30% but had no significant effect on IL-8 secretion. We established a transmigration model showing sequential migration of PMN across microvascular endothelial and renal tubular epithelial cells stimulated by TNF-
and LPS. Anti-inflammatory effects of
-MSH in this bilayer model are demonstrated by inhibition on PMN transmigration and IL-6 secretion.
coculture; polymorphonuclear neutrophil migration; HK-2; interleukin-8; interleukin-6;
-melanocyte-stimulating hormone
Activation of endothelial cells by inflammatory mediators promotes leukocyte infiltration by increased cellular adhesion molecule expression, vascular permeability, and production of chemoattractants (6, 12). Proximal tubular epithelial cells have been shown to act as immune cells and actively participate in the orchestration of inflammatory events (25).
Proximal tubular epithelial cells and the peritubular capillary system are in very close proximity. The onset and progression of impaired renal function is generally based on the defective interplay between tubular and vascular renal compartments. Previous studies have suggested that endothelial and epithelial cells in the kidney form a complex network of interactions. For example, Kim et al. (13) demonstrated that, under hypoxic conditions, proximal tubular epithelial cells induce vascular endothelial growth factor-dependent angiogenesis in cocultured endothelial cells. Furthermore, endothelial cells seem to regulate sodium transport in proximal tubular epithelial cells as shown by Linas and Repine (16). Despite the growing body of knowledge on migration across monolayers of endothelial or epithelial cells, possible interaction between these cell types and the resulting modulation of leukocyte migration have not been studied in depth.
Experimental studies suggest that inhibition of tubulointerstitial inflammation may reduce injury in renal diseases (25). There is evidence that the activation of melanocortin receptors may be a new strategy to control inflammatory processes.
-Melanocyte-stimulating hormone (
-MSH), a potent anti-inflammatory peptide, has been shown to be effective in animal models of local and systemic inflammatory disorders, including sepsis syndrome, and inflammatory bowel disease, and acute renal failure (14, 17, 22). The effects of
-MSH are mediated by melanocortin receptors found on macrophages, polymorphonuclear neutrophils (PMN), and renal tubular cells and acts by inhibiting maladaptive activation of genes that cause inflammatory and cytotoxic injury (5, 10). However, the effect of
-MSH on PMN migration is not known.
Therefore, the focus of our study was to establish a model that more closely mimics the tubulointerstitium, culturing monolayers of human renal proximal tubular epithelial cells (HK-2), and human dermal microvascular endothelial cells (HDMEC) on opposite sides of Transwell growth support. In this bilayer model, we could establish enhanced PMN migration and cytokine production after pretreatment with proinflammatory substances [tumor necrosis factor-
(TNF-
) and endotoxin (LPS)]. Furthermore we could demonstrate a potent anti-inflammatory effect of
-MSH in this model.
| MATERIALS AND METHODS |
|---|
|
|
|---|
HDMEC were obtained from Promocell (Heidelberg, Germany). HDMEC were maintained in MCDB-131 medium containing 1 µg/ml hydrocortisone (Promocell), 10 ng of epidermal growth factor (Promocell), 2 mM L-glutamine (Biological Industries, Kibbutz Beit Haemek, Israel), penicillin (100 U/ml) and streptomycin (100 µg/ml; Sigma Chemical), and 10% FCS at 37°C in a 5% CO2 atmosphere. Passages 4 to 6 were used for experiments.
Isolation of PMN. Human PMN were obtained from the peripheral blood of healthy volunteers (anticoagulated with EDTA) by Lymphoprep density gradient centrifugation, followed by dextran sedimentation and hypotonic lysis of contaminating erythrocytes using aqua bidestillata (Mayrhofer Pharmazeutika, Linz, Austria; see Ref. 27). Cell preparation yielded >95% polymorphonuclear cells (by morphology in Giemsa stain) and >99% viability (by trypan dye exclusion).
Renal endothelium-epithelium monolayer and bilayer construction. HK-2 cells were cultured on the bottom side of Transwell growth support, according to Joannidis et al. (11). A sterilized silicone ring was mounted around the inverted Transwell insert, and 7.5 x 104 HK-2 cells in HK-2 medium (as described above) were added to the chamber. The following day, inserts were reverted and HDMEC cells in HDMEC medium (as described above) were seeded at 3.3 x 104 cells/well. Bilayers were maintained in HDMEC medium. For the epithelial and endothelial monocultures, the same procedure was carried out with the exception that partner cells were not added. Monocultures and cocultures were maintained for 4/5 days in HDMEC medium.
Morphology. Filter-grown mono- and cocultures of the two cell types utilized were fixed for 15 min by 1% glutaraldehyde in PBS. Filters were washed in PBS and postfixed in 1% osmium tetroxide in 0.1 M sodium cacodylate buffer, dehydrated in graded series of isopropanol, and embedded in Durcupane ACM (Fluka, Switzerland). Sectioning for both light (0.5 µm) and electron (0.1 µm) microscopy was performed perpendicular to the cell layer(s). Sections were stained by toluidine blue (light microscopy) or by uranylacetate and lead citrate (electron microscopy).
Assessment of coculture integrity. To confirm that the cocultures were confluent, the growth inserts were inspected daily by light microscopy. Additionally, the following measurements were performed.
Measurement of electrical resistance across the monolayer. The functional integrity was tested using a resistance meter (Endohm; World Pecision Instruments). After establishment of insert cultures, the electrical resistance was monitored on a daily basis until confluence was achieved. All data were corrected for the resistance measurements across blank collagen-coated inserts that showed a resistance of 14.52 ± 2.31
·cm2 (n = 36, data from 6 experiments).
Assessment of the passage of FITC-labeled BSA.
In a series of three experiments, 100 µl of phenol red-free RPMI 1640 (Biochrom; Berlin) containing 100 µg/ml FITC-BSA (Sigma, Chemical) were added to the apical compartment, and its passage across the coculture was monitored after 10 min and 4 h by sampling the apical and basolateral supernatant and measuring the fluorescent activity using the Cytofluor 2350 fluorescence system (Millipore). The ratio of fluorescence activity between the two samples was calculated. Filter alone without cells developed
20% of equilibrium within 10 min, which increased to roughly 50% after 4 h (n = 3). In contrast, when HK-2 cells and HDMEC were cocultured on the growth support inserts, <1% and 5% (n = 3) of equilibrium was measured after 10 min and 4 h, respectively. Bilayers that exhibited an electrical resistance of >16
·cm2 showed a permeability of <5% FITC-BSA, indicating that a tight barrier was formed.
Leukocyte transmigration experiments.
Preliminary experiments determined both the time courses and the appropriate number of PMN to add to the upper chamber of the Transwell growth arrest. Transmigration experiments were performed as previously described (11). Confluent monolayers or cocultures (composed of confluent HK-2 on the lower and confluent HDMEC cells on the upper side of the Transwell inserts) were washed two times in PBS and incubated with TNF-
(50 ng/ml) or LPS (100 µg/ml) for 4 h. Incubation of the monolayers with the test substances was followed by washing the upper and lower surfaces of the Transwell filter cups two times with PBS and then transferring them to new, clean wells. Next, 0.1 ml of PMN suspension (2.0 x 106 cells/ml) was added to the upper compartments, and PMN were allowed to migrate across the bilayer for 5 h.
PMN contents of the cell layers and lower compartments were quantified by assaying the azurophil granule marker myeloperoxidase (MPO) as described previously (20) with slight modifications. Briefly, inserts containing the cocultures were washed four times with Hanks balanced salt solution (HBSS) to remove nonmigrated PMN. HBSS (0.6 ml) containing 10% Triton X-100 was added to the lower compartment to release the MPO from the neutrophils. The pH was adjusted with 100 µl of 1 M citrate buffer, pH 4.2. Color development was assayed at 405 nm on a microtiter plate reader (Labsystems Bioscan; Biochromatic) after mixing equal parts of sample and a solution containing 1 mM 2,2'-azino-di-(3-ethly)-dithiazoline sulfonic acid (Sigma Chemical) and 10 mM H2O2 (Sigma Chemical) in 100 mM citrate buffer, pH 4.2. After 5 min, the reaction was terminated by the addition of SDS to a final concentration of 0.5%. The assay was standardized with known numbers of the same PMN used in each individual experiment and was linear in the range used (0105 cells). MPO activity was negligible in lysates of cocultures unexposed to PMN.
In a subset of experiments, the bilayers were preincubated with various concentrations of
-MSH (107 to 1012 M) for 424 h. Each independent experiment was performed in duplicate. Because of the variations between the individual sets of experiments, data are expressed as "migration index," which represents the ratio of PMN migration across stimulated cocultures and through unstimulated coculture in each experiment.
Cytokine release measurements.
Supernatants were collected from the upper (endothelial) and lower (epithelial) compartment after 4 h of incubation with TNF-
![]()
Statistical analysis. The data are expressed as means ± SE. Unless indicated differently, each independent experiment in transmigration experiments was performed with cells from a different donor. Differences between means were tested for statistical significance. Student's t-test or Mann-Whitney test was applied as appropriate. If ratios of stimulated migration were compared with controls (i.e., index = "1") one-sample t-test for difference from a hypothetical mean (i.e., 1) was applied. If several experiments were compared against each other, one-way ANOVA followed by Bonferroni test for selected pairs was performed. P < 0.05 was considered statistically significant. GraphPad PRISM version 3.03 (GraphPad Software) was used for statistical analysis.
| RESULTS |
|---|
|
|
|---|
|
|
(50 ng/ml) and LPS (100 µg/ml; Fig. 3) significantly increased the baseline transmigration across the cocultures by a factor of 2.76 ± 0.64 and 3.5 ± 0.58, respectively. A similar increase in transmigration index was observed when PMN were allowed to migrate toward a concentration gradient of the chemoattractant N-formyl-Met-Leu-Phe (fMLP) (106 M) in the epithelial compartment (migration index 2.51 ± 0.63).
|
|
|
-MSH on PMN migration.
The effect of
-MSH on PMN migration across the coculture bilayer model was investigated.
-MSH resulted in a decreased PMN migration across the unstimulated coculture bilayer and resulted in a dose-dependent decrease in PMN migration across LPS-stimulated cells (Fig. 6A).
-MSH showed a maximal reversal of LPS-induced PMN migration at 9 h (Fig. 6B). There was no significant reversal of
-MSH on PMN migration in TNF-
-stimulated cells (Fig. 6C).
|
-MSH on cytokine release.
-MSH did not have a significant effect on cytokine production when cells were unstimulated. However,
-MSH at 107 M did result in a decrease in IL-6 release from LPS-stimulated cocultures by 32.3% (Fig. 7A). IL-8 secretion was not significantly affected by
-MSH (Fig. 7B).
|
| DISCUSSION |
|---|
|
|
|---|
In an attempt to mimic this in vivo situation, we developed a bilayer model that allows communication and interaction of human endothelial and tubular epithelial cells cultured on opposite sides of Transwell growth supports. This model responded with enhanced PMN migration and cytokine production after pretreatment with proinflammatory mediators (TNF-
and LPS). Incubation with
-MSH showed partial suppression of PMN migration through the bilayer stimulated by LPS and diminished IL-6 production.
Only a few studies focused on endothelial-tubular epithelial cell interactions (9, 12). They mainly used a sandwich coculture method culturing endothelial cells on confluent monolayers of tubular epithelial cells. Because tubular epithelial cells show a highly polarized expression and secretion of molecules (11, 12), the physiological orientation of the cells in the bilayer model (basal side of the endothelial cells opposed to the basolateral surface of the epithelial cells) is likely to be relevant for cell-cell interactions.
After stimulation of the bilayer with TNF-
and LPS, a significant transmigration of PMN could be detected. The efficiency of PMN migration across the endothelial monolayer was threefold higher than through the epithelial monolayer alone. Interestingly, the presence of a second cell layer did not impede the movement of PMN. The sequential endothelial/epithelial migration was lower than migration across the HDMEC monolayers and not different from migration across HK-2 monolayers although an additional cell barrier had to be passed by the PMN. A similar observation was also made with respiratory epithelia by Mul et al. (18). They noted an even higher migration through a bilayer that equaled the migration through single endothelial monolayers. Several mechanisms are considered to be responsible for this phenomenon. Transendothelial migration may increase leukocyte motility, facilitating the subsequent passage through the epithelial monolayer. It has been reported that diapedesis through the endothelium leads to changes of the leukocyte physiology. PMN, in contact with inflammatory endothelium, showed reduced apoptotic activity and enhanced phagocytosis (19). We observed that the number of monolayer- and bilayer-associated PMN (PMN that only partly traverse the cell barriers) was comparable, indicating that accumulation between the two cell layers did not occur (data not shown). Additionally, endothelial and epithelial cells may influence each other through the release of soluble factors promoting migration across the bilayer. In the cocultures, there was a higher concentration of IL-6 and IL-8 in the upper (endothelial) compartment compared with endothelial monocultures. Although it would be possible to interpret these findings as enhanced cytokine production by the endothelial cells under the condition of coculture with epithelia, it is most likely that cytokines were released by the basolateral membrane of the epithelial cells and consequently crossed the endothelial cell layer. IL-6 is known to inhibit apoptosis of PMN in vitro (6), whereas IL-8, a potent chemoattractant that can be produced by endothelial and epithelial cells (2), plays a critical role in recruitment of PMN to sites of inflammation (26).
Excessive recruitment of PMN in the tubulointerstitium is associated with tissue damage and deterioration of renal function. Decreased PMN migration into areas of inflammation is considered to exert a beneficial effect. In previous studies,
-MSH, a neuropeptide with broad anti-inflammatory properties, showed renoprotective effects in animal models of ischemia and endotoxemia (22). In this study, we demonstrate that
-MSH inhibits PMN migration across a human endothelial/tubular epithelial bilayer in a time- and dose-dependent manner after stimulation with LPS. In contrast, the inhibitory effect of
-MSH on TNF-
-stimulated migration was only weak and did not reach statistical significance. Why the inhibitory effect of
-MSH was more pronounced after LPS stimulation remains unclear. Scholzen et al. (24) demonstrated that
-MSH reduced, via a not yet identified mechanism, the inflammatory response of various stimuli, including LPS, TNF-
, and IL-1. Although
-MSH acts as a potent inhibitor of LPS-activated nuclear factor-
B, the effect of
-MSH on TNF-
-treated endothelial cells could be mimicked by the protein kinase A activator forskolin. This indicates that
-MSH may exert its effect by interfering with several signal transduction pathways, e.g., via elevation of cAMP (4), protein kinase C (3), or intracellular calcium release (8).
The inhibitory effect of
-MSH peaked at 9 h when added simultaneously with LPS to the bilayer. PMN express the MC-1 receptor and
-MSH reduces chemotaxis (4). One could speculate that the reduced chemotactic activity might be responsible for the observed reduction of PMN migration. However, application of
-MSH after stimulation with LPS resulted in a minor inhibition of migration. This suggests
-MSH may affect both the PMN and the endothelial cells. Although an anti-inflammatory and cytoprotective effect of
-MSH have been reported also for tubular epithelial cells (10, 14),transmigration across HK-2 monolayers was not influenced by
-MSH (data not shown), making their importance in
-MSH-inhibited migration unlikely.
Our data show sequential migration of PMN across endothelial and renal tubular epithelial cells. Transmigration is stimulated by TNF-
and LPS. Anti-inflammatory effects of
-MSH could be verified on this bilayer model after incubation with LPS.
-MSH inhibits IL-6 secretion stimulated by LPS in the bilayer model. We believe that this model will be important in the further investigation of signaling pathways between tubular epithelial and microvascular endothelial interactions in C: the kidney.
| GRANTS |
|---|
|
|
|---|
| ACKNOWLEDGMENTS |
|---|
| FOOTNOTES |
|---|
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
| REFERENCES |
|---|
|
|
|---|
2. Bittleman DB, Casale TB. Interleukin-8 mediates interleukin-1 alpha-induced neutrophil transcellular migration. Am J Respir Cell Mol Biol 13: 323329, 1995.[Abstract]
3. Buffey J, Thody AJ, Bleehen SS, Mac NS. Alpha-melanocyte-stimulating hormone stimulates protein kinase C activity in murine B16 melanoma. J Endocrinol 133: 333340, 1992.
4. Catania A, Rajora N, Capsoni F, Minonzio F, Star RA, Lipton JM. The neuropeptide alpha-MSH has specific receptors on neutrophils and reduces chemotaxis in vitro. Peptides 17: 675679, 1996.[CrossRef][Web of Science][Medline]
5. Chiao H, Kohda Y, McLeroy P, Craig L, Housini I, Star RA. Alpha-melanocyte-stimulating hormone protects against renal injury after ischemia in mice and rats. J Clin Invest 99: 11651172, 1997.[Web of Science][Medline]
6. Coxon A, Tang T, Mayadas TN. Cytokine-activated endothelial cells delay neutrophil apoptosis in vitro and in vivo. A role for granulocyte/macrophage colony-stimulating factor. J Exp Med 190: 923934, 1999.
7. Daffern PJ, Jagels MA, Hugli TE. Multiple epithelial cell-derived factors enhance neutrophil survival. Regulation by glucocorticoids and tumor necrosis factor-alpha. Am J Respir Cell Mol Biol 21: 259267, 1999.
8. Elliott RJ, Szabo M, Wagner MJ, Kemp EH, MacNeil S, Haycock JW. alpha-Melanocyte-stimulating hormone, MSH 1113 KPV and adrenocorticotropic hormone signaling in human keratinocyte cells. J Invest Dermatol 122: 10101019, 2004.[CrossRef][Web of Science][Medline]
9. Friedmann PS, Wren F, Buffey J, MacNeil S. Alpha-MSH causes a small rise in cAMP but has no effect on basal or ultraviolet-stimulated melanogenesis in human melanocytes. Br J Dermatol 123: 145151, 1990.[CrossRef][Web of Science][Medline]
10. Jo SK, Lee SY, Han SY, Cha DR, Cho WY, Kim HK, Won NH. alpha-Melanocyte stimulating hormone (MSH) decreases cyclosporine a induced apoptosis in cultured human proximal tubular cells. J Korean Med Sci 16: 603609, 2001.[Web of Science][Medline]
11. Joannidis M, Truebsbach S, Bijuklic K, Schratzberger P, Dunzedorfer S, Wintersteiger S, Lhotta K, Mayer G, Wiedermann CJ. Neutrophil transmigration in renal proximal tubular LLC-PK1 cells. Cell Physiol Biochem 14: 101112, 2004.[CrossRef][Web of Science][Medline]
12. Kapper S, Beck G, Riedel S, Prem K, Haak M, van der Woude FJ, Yard BA. Modulation of chemokine production and expression of adhesion molecules in renal tubular epithelial and endothelial cells by catecholamines. Transplantation 74: 253260, 2002.[CrossRef][Web of Science][Medline]
13. Kim BS, Chen J, Weinstein T, Noiri E, Goligorsky MS. VEGF expression in hypoxia and hyperglycaemia: reciprocal effect on branching angiogenesis in epithelial-endothelial co-cultures. J Am Soc Nephrol 13: 20272036, 2002.
14. Kohda Y, Chiao H, Star RA. alpha-Melanocyte-stimulating hormone and acute renal failure. Curr Opin Nephrol Hyperten 7: 413417, 1998.[Web of Science][Medline]
15. Lechner J, Krall M, Netzer A, Radmayr C, Ryan MP, Pfaller W. Effects of interferon alpha-2b on barrier function and junctional complexes of renal proximal tubular LLC-PK1 cells. Kidney Int 55: 21782191, 1999.[CrossRef][Web of Science][Medline]
16. Linas SL, Repine JE. Endothelial cells regulate proximal tubule epithelial cell sodium transport. Kidney Int 55: 12511258, 1999.[CrossRef][Web of Science][Medline]
17. MacNeil S, Dobson J, Bleehen SS, Buffey JA. MSH increases intracellular calcium in melanoma cells. Br J Dermol 123: 828834, 1990.
18. Mul FP, Zuurbier AE, Janssen H, Calafat J, van Wetering S, Hiemstra PS, Roos D, Hordijk PL. Sequential migration of neutrophils across monolayers of endothelial and epithelial cells. J Leukoc Biol 68: 529537, 2000.
19. Pardi R, Inverardi L, Bender JR. Regulatory mechanisms in leukocyte adhesion: flexible receptors for sophisticated travellers. Immunol Today 13: 93100, 1992.[CrossRef][Web of Science][Medline]
20. Parkos CA, Delp C, Arnaout MA, Madara JL. Neutrophil migration across a cultured intestinal epithelium. Dependence on a CD11b/CD18-mediated event and enhanced efficiency in physiological direction. J Clin Invest 88: 16051612, 1991.[Web of Science][Medline]
21. Parkos CA. Cell adhesion and migration. I. Neutrophil adhesive interactions with intestinal epithelium. Am J Physiol Gastrointest Liver Physiol 273: G763G768, 1997.
22. Rajora N, Boccoli G, Catania A, Lipton JM. alpha-MSH modulates experimental inflammatory bowel disease. Peptides 18: 381385, 1997.[CrossRef][Web of Science][Medline]
23. Ryan MJ, Johnson G, Kirk J, Fuerstenberg SM, Zager RA, Torok-Storb B. HK-2: an immortalized proximal tubule epithelial cell line from normal adult human kidney. Kidney Int 45: 4857, 1994.[Web of Science][Medline]
24. Scholzen TE, Sunderkotter C, Kalden DH, Brzoska T, Fastrich M, Fisbeck T, Armstrong CA, Ansel JC, Luger TA. Alpha-melanocyte stimulating hormone prevents lipopolysaccharide-induced vasculitis by down-regulating endothelial cell adhesion molecule expression. Endocrinology 144: 360370, 2003.
25. Star RA. Treatment of acute renal failure. Kidney Int 54: 18171831, 1998.[CrossRef][Web of Science][Medline]
26. van Kooten C, Daha MR. Cytokine cross-talk between tubular epithelial cells and interstitial immunocompetent cell. Curr Opin Nephrol Hypertens 10: 5559, 2001.[CrossRef][Web of Science][Medline]
27. Wiedermann CJ, Niedermuhlbichler M, Braunsteiner H, Widermann CJ. Priming of polymorphonuclear neutrophils by atrial natriuretic peptide in vitro. J Clin Invest 89: 15801586, 1992.[Web of Science][Medline]
28. Zen K, Parkos CA. Leukocyte-epithelial interactions. Curr Opin Cell Biol 15: 557564, 2003.[CrossRef][Web of Science][Medline]
29. Zimmerman GA, Prescott SM, McIntyre TM. Endothelial cell interaction with granuolcytes, tethering and signaling molecules. Immunol Today 13: 93100, 1992.[CrossRef][Web of Science][Medline]
This article has been cited by other articles:
![]() |
W. Wang, W. Brian Reeves, and G. Ramesh Netrin-1 and kidney injury. I. Netrin-1 protects against ischemia-reperfusion injury of the kidney Am J Physiol Renal Physiol, April 1, 2008; 294(4): F739 - F747. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Aydin, S. Signorelli, T. Lechleitner, M. Joannidis, C. Pleban, P. Perco, W. Pfaller, and P. Jennings Influence of microvascular endothelial cells on transcriptional regulation of proximal tubular epithelial cells Am J Physiol Cell Physiol, February 1, 2008; 294(2): C543 - C554. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |